BURLINGTON, N.C.--(BUSINESS WIRE)--LabCorp® (NYSE: LH), a leading global life sciences company, announced today that it has received approval from the U.S. Food and Drug Administration (FDA) for the ...

Laboratory Corporation of America Holdings (LabCorp) is the first national clinical laboratory to offer HCV PCR testing using a newly FDA approved assay, the Roche COBAS AmpliPrep/COBAS TaqMan HCV ...

Occult HCV infection is defined by the existence of an HCV-RNA-positive strand in the serum, lymphoid cells (peripheral blood mononuclear cells [PBMCs]) and/or the liver, and the detection of a ...

According to a new study presented at The Liver Meeting, combining universal screening for the hepatitis C virus (HCV) with reflex RNA PCR in pregnant women is more cost-effective than risk-based ...

Chronic hepatitis C infection affects an estimated 50 million people globally, causes approximately 242,000 deaths per year mostly due to cirrhosis and liver cancer Same-day results will help ...

Agreement Significantly Adds to the North American Test Menus of Both Parties and Aims to Increase the Adoption of HPV Screening GERMANTOWN, Maryland and DES PLAINES ...

This faster polymerase chain test (PCR) allows same-day diagnosis and prompt treatment for the people affected with liver disease. This expeditious assessment aims to prevent costly and ruinous ...

Researchers from Model Medicines Inc. have presented preclinical efficacy data for MDL-001, a first-in-class, oral non-nucleoside inhibitor that targets an allosteric site in the Thumb-1 domain of the ...

Data of patients with CHC available from medical records were retrospectively analyzed. Patients were eligible for the study if they had serologically and virologically confirmed chronic HCV infection ...

To develop the new rapid polymerase chain reaction (PCR) test for HCV, the scientists used the DASH® (Diagnostic Analyzer for Specific Hybridization)PCR platform, which was originally developed at ...